HEADER LIGASE/LIGASE INHIBITOR 03-MAR-23 8GCY TITLE CO-CRYSTAL STRUCTURE OF CBL-B IN COMPLEX WITH N-ARYL ISOINDOLIN-1-ONE TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: E3 UBIQUITIN-PROTEIN LIGASE CBL-B; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CASITAS B-LINEAGE LYMPHOMA PROTO-ONCOGENE B,RING FINGER COMPND 5 PROTEIN 56,RING-TYPE E3 UBIQUITIN TRANSFERASE CBL-B,SH3-BINDING COMPND 6 PROTEIN CBL-B,SIGNAL TRANSDUCTION PROTEIN CBL-B; COMPND 7 EC: 2.3.2.27; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CBLB, RNF56, NBLA00127; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS E3 LIGASE, CBL-B, INHIBITOR, SGC, LIGASE, LIGASE-LIGASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.KIMANI,H.ZENG,A.DONG,Y.LI,V.SANTHAKUMAR,C.H.ARROWSMITH,A.M.EDWARDS, AUTHOR 2 L.HALABELIAN,STRUCTURAL GENOMICS CONSORTIUM (SGC) REVDAT 2 03-APR-24 8GCY 1 JRNL REVDAT 1 22-MAR-23 8GCY 0 JRNL AUTH S.W.KIMANI,S.PERVEEN,M.SZEWEZYK,H.ZENG,A.DONG,F.LI,P.GHIABI, JRNL AUTH 2 Y.LI,I.CHAU,C.H.ARROWSMITH,D.BARSYTE-LOVEJOY,V.SANTHAKUMAR, JRNL AUTH 3 M.VEDADI,L.HALABELIAN JRNL TITL THE CO-CRYSTAL STRUCTURE OF CBL-B AND A SMALL-MOLECULE JRNL TITL 2 INHIBITOR REVEALS THE MECHANISM OF CBL-B INHIBITION. JRNL REF COMMUN BIOL V. 6 1272 2023 JRNL REFN ESSN 2399-3642 JRNL PMID 38104184 JRNL DOI 10.1038/S42003-023-05655-8 REMARK 2 REMARK 2 RESOLUTION. 1.81 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REFMAC 5.8.0258 REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.81 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.68 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 3 NUMBER OF REFLECTIONS : 33780 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.197 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.230 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1795 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2966 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 51 REMARK 3 SOLVENT ATOMS : 142 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.20000 REMARK 3 B22 (A**2) : 2.69000 REMARK 3 B33 (A**2) : -1.49000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.142 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.131 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.107 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.580 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 8GCY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-MAR-23. REMARK 100 THE DEPOSITION ID IS D_1000272621. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-FEB-23 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-E REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97918 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35624 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.810 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 10.90 REMARK 200 R MERGE (I) : 0.06400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 36.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.81 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.84 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.3 REMARK 200 DATA REDUNDANCY IN SHELL : 9.90 REMARK 200 R MERGE FOR SHELL (I) : 0.94000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.25 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M IMIDAZOLE, 0.1 M MES MONOHYDRATE REMARK 280 PH 6.5 0.09 M SODIUM NITRATE, 0.09 M SODIUM PHOSPHATE DIBASIC, REMARK 280 0.09M AMMONIUM SULFATE 12.5% V/V MPD; 12.5% PEG1000; 12.5% W/V REMARK 280 PEG 3350, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.96850 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 52.73200 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.04650 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 52.73200 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.96850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.04650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 339 REMARK 465 ASP A 340 REMARK 465 LEU A 341 REMARK 465 THR A 342 REMARK 465 GLY A 343 REMARK 465 LEU A 344 REMARK 465 CYS A 345 REMARK 465 GLU A 346 REMARK 465 PRO A 347 REMARK 465 THR A 348 REMARK 465 PRO A 349 REMARK 465 HIS A 350 REMARK 465 ASP A 351 REMARK 465 HIS A 352 REMARK 465 ILE A 353 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 44 CD NE CZ NH1 NH2 REMARK 470 LYS A 48 CE NZ REMARK 470 LYS A 64 CE NZ REMARK 470 LYS A 68 CG CD CE NZ REMARK 470 ASN A 69 CG OD1 ND2 REMARK 470 SER A 70 OG REMARK 470 TYR A 73 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLN A 100 CG CD OE1 NE2 REMARK 470 GLU A 103 CG CD OE1 OE2 REMARK 470 GLU A 105 CD OE1 OE2 REMARK 470 LYS A 108 CE NZ REMARK 470 LYS A 126 CE NZ REMARK 470 LYS A 129 CD CE NZ REMARK 470 GLU A 135 CG CD OE1 OE2 REMARK 470 GLN A 136 CG CD OE1 NE2 REMARK 470 ARG A 172 CZ NH1 NH2 REMARK 470 LYS A 184 CE NZ REMARK 470 GLU A 203 CG CD OE1 OE2 REMARK 470 LYS A 275 CE NZ REMARK 470 SER A 277 OG REMARK 470 GLN A 308 CD OE1 NE2 REMARK 470 GLU A 326 CD OE1 OE2 REMARK 470 ARG A 335 CG CD NE CZ NH1 NH2 REMARK 470 SER A 336 OG REMARK 470 ASN A 338 CG OD1 ND2 REMARK 470 LYS A 354 CG CD CE NZ REMARK 470 LYS A 374 CD CE NZ REMARK 470 GLU A 378 CD OE1 OE2 REMARK 470 SER A 403 OG REMARK 470 GLN A 406 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 70 83.47 -160.41 REMARK 500 LYS A 129 -132.07 54.46 REMARK 500 ASN A 163 29.94 45.60 REMARK 500 SER A 208 -79.82 -84.22 REMARK 500 ALA A 262 -141.91 54.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 501 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 373 SG REMARK 620 2 CYS A 376 SG 109.0 REMARK 620 3 CYS A 393 SG 112.9 111.0 REMARK 620 4 CYS A 396 SG 116.7 107.1 99.6 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 502 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 388 SG REMARK 620 2 HIS A 390 ND1 106.9 REMARK 620 3 CYS A 408 SG 109.2 110.6 REMARK 620 4 CYS A 411 SG 107.2 112.0 110.8 REMARK 620 N 1 2 3 DBREF 8GCY A 38 427 UNP Q13191 CBLB_HUMAN 38 427 SEQADV 8GCY GLY A 37 UNP Q13191 EXPRESSION TAG SEQADV 8GCY ALA A 51 UNP Q13191 LYS 51 CONFLICT SEQADV 8GCY ALA A 55 UNP Q13191 LYS 55 CONFLICT SEQADV 8GCY ALA A 325 UNP Q13191 ARG 325 CONFLICT SEQADV 8GCY PHE A 360 UNP Q13191 TYR 360 CONFLICT SEQRES 1 A 391 GLY GLN ALA ALA ALA ASP ARG ARG THR VAL GLU LYS THR SEQRES 2 A 391 TRP ALA LEU MET ASP ALA VAL VAL ARG LEU CYS GLN ASN SEQRES 3 A 391 PRO LYS LEU GLN LEU LYS ASN SER PRO PRO TYR ILE LEU SEQRES 4 A 391 ASP ILE LEU PRO ASP THR TYR GLN HIS LEU ARG LEU ILE SEQRES 5 A 391 LEU SER LYS TYR ASP ASP ASN GLN LYS LEU ALA GLN LEU SEQRES 6 A 391 SER GLU ASN GLU TYR PHE LYS ILE TYR ILE ASP SER LEU SEQRES 7 A 391 MET LYS LYS SER LYS ARG ALA ILE ARG LEU PHE LYS GLU SEQRES 8 A 391 GLY LYS GLU ARG MET TYR GLU GLU GLN SER GLN ASP ARG SEQRES 9 A 391 ARG ASN LEU THR LYS LEU SER LEU ILE PHE SER HIS MET SEQRES 10 A 391 LEU ALA GLU ILE LYS ALA ILE PHE PRO ASN GLY GLN PHE SEQRES 11 A 391 GLN GLY ASP ASN PHE ARG ILE THR LYS ALA ASP ALA ALA SEQRES 12 A 391 GLU PHE TRP ARG LYS PHE PHE GLY ASP LYS THR ILE VAL SEQRES 13 A 391 PRO TRP LYS VAL PHE ARG GLN CYS LEU HIS GLU VAL HIS SEQRES 14 A 391 GLN ILE SER SER GLY LEU GLU ALA MET ALA LEU LYS SER SEQRES 15 A 391 THR ILE ASP LEU THR CYS ASN ASP TYR ILE SER VAL PHE SEQRES 16 A 391 GLU PHE ASP ILE PHE THR ARG LEU PHE GLN PRO TRP GLY SEQRES 17 A 391 SER ILE LEU ARG ASN TRP ASN PHE LEU ALA VAL THR HIS SEQRES 18 A 391 PRO GLY TYR MET ALA PHE LEU THR TYR ASP GLU VAL LYS SEQRES 19 A 391 ALA ARG LEU GLN LYS TYR SER THR LYS PRO GLY SER TYR SEQRES 20 A 391 ILE PHE ARG LEU SER CYS THR ARG LEU GLY GLN TRP ALA SEQRES 21 A 391 ILE GLY TYR VAL THR GLY ASP GLY ASN ILE LEU GLN THR SEQRES 22 A 391 ILE PRO HIS ASN LYS PRO LEU PHE GLN ALA LEU ILE ASP SEQRES 23 A 391 GLY SER ALA GLU GLY PHE TYR LEU TYR PRO ASP GLY ARG SEQRES 24 A 391 SER TYR ASN PRO ASP LEU THR GLY LEU CYS GLU PRO THR SEQRES 25 A 391 PRO HIS ASP HIS ILE LYS VAL THR GLN GLU GLN PHE GLU SEQRES 26 A 391 LEU TYR CYS GLU MET GLY SER THR PHE GLN LEU CYS LYS SEQRES 27 A 391 ILE CYS ALA GLU ASN ASP LYS ASP VAL LYS ILE GLU PRO SEQRES 28 A 391 CYS GLY HIS LEU MET CYS THR SER CYS LEU THR ALA TRP SEQRES 29 A 391 GLN GLU SER ASP GLY GLN GLY CYS PRO PHE CYS ARG CYS SEQRES 30 A 391 GLU ILE LYS GLY THR GLU PRO ILE ILE VAL ASP PRO PHE SEQRES 31 A 391 ASP HET ZN A 501 1 HET ZN A 502 1 HET Z3N A 503 39 HET EDO A 504 4 HET SO4 A 505 5 HET UNX A 506 1 HETNAM ZN ZINC ION HETNAM Z3N 2-{3-[(1S,3R)-3-METHYL-1-(4-METHYL-4H-1,2,4-TRIAZOL-3- HETNAM 2 Z3N YL)CYCLOBUTYL]PHENYL}-6-{[(3S)-3-METHYLPIPERIDIN-1- HETNAM 3 Z3N YL]METHYL}-4-(TRIFLUOROMETHYL)-2,3-DIHYDRO-1H- HETNAM 4 Z3N ISOINDOL-1-ONE HETNAM EDO 1,2-ETHANEDIOL HETNAM SO4 SULFATE ION HETNAM UNX UNKNOWN ATOM OR ION HETSYN EDO ETHYLENE GLYCOL FORMUL 2 ZN 2(ZN 2+) FORMUL 4 Z3N C30 H34 F3 N5 O FORMUL 5 EDO C2 H6 O2 FORMUL 6 SO4 O4 S 2- FORMUL 7 UNX X FORMUL 8 HOH *142(H2 O) HELIX 1 AA1 GLN A 38 GLN A 61 1 24 HELIX 2 AA2 ASN A 62 GLN A 66 5 5 HELIX 3 AA3 TYR A 73 TYR A 92 1 20 HELIX 4 AA4 ASP A 94 GLU A 103 1 10 HELIX 5 AA5 ASN A 104 LYS A 129 1 26 HELIX 6 AA6 GLU A 130 GLU A 134 5 5 HELIX 7 AA7 SER A 137 PHE A 161 1 25 HELIX 8 AA8 PRO A 162 GLN A 165 5 4 HELIX 9 AA9 GLN A 167 PHE A 171 5 5 HELIX 10 AB1 LYS A 175 GLY A 187 1 13 HELIX 11 AB2 TRP A 194 HIS A 205 1 12 HELIX 12 AB3 SER A 209 ASP A 221 1 13 HELIX 13 AB4 VAL A 230 GLN A 241 1 12 HELIX 14 AB5 PRO A 242 GLY A 244 5 3 HELIX 15 AB6 SER A 245 ALA A 254 1 10 HELIX 16 AB7 THR A 265 LYS A 275 1 11 HELIX 17 AB8 PRO A 315 GLU A 326 1 12 HELIX 18 AB9 THR A 356 MET A 366 1 11 HELIX 19 AC1 CYS A 393 SER A 403 1 11 SHEET 1 AA1 2 ILE A 191 PRO A 193 0 SHEET 2 AA1 2 TYR A 227 SER A 229 -1 O ILE A 228 N VAL A 192 SHEET 1 AA2 4 TYR A 260 PHE A 263 0 SHEET 2 AA2 4 SER A 282 LEU A 287 1 O LEU A 287 N ALA A 262 SHEET 3 AA2 4 TRP A 295 VAL A 300 -1 O GLY A 298 N ILE A 284 SHEET 4 AA2 4 ILE A 306 THR A 309 -1 O THR A 309 N ILE A 297 SHEET 1 AA3 3 TYR A 260 PHE A 263 0 SHEET 2 AA3 3 SER A 282 LEU A 287 1 O LEU A 287 N ALA A 262 SHEET 3 AA3 3 TYR A 331 PRO A 332 1 O TYR A 331 N TYR A 283 SHEET 1 AA4 3 LEU A 391 MET A 392 0 SHEET 2 AA4 3 VAL A 383 GLU A 386 -1 N VAL A 383 O MET A 392 SHEET 3 AA4 3 GLY A 417 PRO A 420 -1 O GLY A 417 N GLU A 386 LINK SG CYS A 373 ZN ZN A 501 1555 1555 2.29 LINK SG CYS A 376 ZN ZN A 501 1555 1555 2.36 LINK SG CYS A 388 ZN ZN A 502 1555 1555 2.30 LINK ND1 HIS A 390 ZN ZN A 502 1555 1555 2.10 LINK SG CYS A 393 ZN ZN A 501 1555 1555 2.33 LINK SG CYS A 396 ZN ZN A 501 1555 1555 2.33 LINK SG CYS A 408 ZN ZN A 502 1555 1555 2.29 LINK SG CYS A 411 ZN ZN A 502 1555 1555 2.33 CISPEP 1 PRO A 71 PRO A 72 0 29.31 CISPEP 2 GLN A 241 PRO A 242 0 -2.71 CISPEP 3 GLU A 386 PRO A 387 0 7.32 CRYST1 47.937 76.093 105.464 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020861 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013142 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009482 0.00000